Related scientific articles (all)

Early invasive cancer and partial intraoperative electron radiation therapy of the breast: experience of the jules bordet institute.

Authors : Philippson C, Simon S, Vandekerkhove C, Hertens D, Veys I, Noterman D, De Neubourg F, Larsimont D, Bourgeois P, Van Houtte P, Nogaret JM
Year : 2014
Journal : Int J Breast Cancer
Volume : 2014
Pages : 627352

Pretreatment Dosimetry in HCC Radioembolization with 90Y Glass Microspheres Cannot Be Invalidated with a Bare Visual Evaluation of 99mTc-MAA Uptake of Colorectal Metastases Treated with Resin Microspheres.

Authors : Chiesa C, Lambert B, Maccauro M, Ezziddin S, Ahmadzadehfar H, Dieudonné A, Cremonesi M, Konijnenberg M, Lassmann M, Pettinato C, Strigari L, Vanderlinden B, Crippa F, Flamen P, Garin E
Year : 2014
Journal : J. Nucl. Med.
Volume : 55(7)
Pages : 1215-16

Correlating tumor metabolic progression index measured by serial FDG PET-CT, apparent diffusion coefficient measured by magnetic resonance imaging (MRI) and blood genomics to patient's outcome in advanced colorectal cancer: the CORIOLAN study.

Authors : Deleporte A, Paesmans M, Garcia C, Vandeputte C, Lemort M, Engelholm JL, Hoerner F, Aftimos P, Awada A, Charette N, Machiels G, Piccart-Gebhart M, Flamen P, Hendlisz A
Year : 2014
Journal : BMC Cancer
Volume : 14(1)
Pages : 385

A phase IIa, nonrandomized study of radium-223 dichloride in advanced breast cancer patients with bone-dominant disease.

Authors : Coleman R, Aksnes AK, Naume B, Garcia C, Jerusalem G, Piccart-Gebhart M, Vobecky N, Thuresson M, Flamen P
Year : 2014
Journal : Breast Cancer Res. Treat.
Volume : 145(2)
Pages : 411-8

Tumor Texture Analysis in 18F-FDG PET: Relationships Between Texture Parameters, Histogram Indices, Standardized Uptake Values, Metabolic Volumes, and Total Lesion Glycolysis.

Authors : Orlhac F, Soussan M, Maisonobe JA, Garcia C, Vanderlinden B, Buvat I
Year : 2014
Journal : J. Nucl. Med.
Volume : 55(3)
Pages : 414-22

Multicenter Harmonization of 89Zr PET/CT Performance.

Authors : Makris NE, Boellaard R, Visser EP, de Jong JR, Vanderlinden B, Wierts R, van der Veen BJ, Greuter HJ, Vugts DJ, van Dongen GA, Lammertsma AA, Huisman MC
Year : 2014
Journal : J. Nucl. Med.
Volume : 55(2)
Pages : 264-7

Reply to Letter re: General Theory of Predictive Dosimetry for Yttrium-90 Radioembolization to Sites Other Than the Liver.

Authors : Muylle K, Vanderlinden B
Year : 2014
Journal : Cardiovasc Intervent Radiol
Volume : 37(4)
Pages : 1118-19

Comparison of PET metabolic indices for the early assessment of tumour response in metastatic colorectal cancer patients treated by polychemotherapy.

Authors : Maisonobe JA, Garcia C, Necib H, Vanderlinden B, Hendlisz A, Flamen P, Buvat I
Year : 2013
Journal : Eur J Nucl Med Mol Imaging
Volume : 40(2)
Pages : 166-74

Radioembolization of the Spleen: A Revisited Approach for the Treatment of Malignant Lymphomatous Splenomegaly. (epub online 2012)

Authors : Muylle K, Nguyen J, de Wind A, Meuleman N, Delatte P, Vanderlinden B, Roelandts M, Vanderstappen A, Bron D, Flamen P
Year : 2013
Journal : Cardiovasc Intervent Radiol
Volume : 36(4)
Pages : 1155-60

Histiocytose agressive à cellules de Langerhans 20 ans après un cancer du sein : à propos d’un cas.

Authors : Zakkouri F, Klastersky J, Alexiou J, de Saint-Aubain de Somerhausen N, Flamen P, Firescu R, Georgala A, Awada A
Year : 2013
Journal : J Am Soc Echocardiogr
Volume : 5
Pages : 220-223

Contributions of SPECT/CT imaging to the lymphoscintigraphic investigations of the lower limb lymphedema.

Authors : Baulieu F, Bourgeois P, Maruani A, Belgrado JP, Tauveron V, Lorette G, Vaillant L
Year : 2013
Journal : Lymphology
Volume : 46(3)
Pages : 106-19

18F-FDG PET/CT for Early Prediction of Response to Neoadjuvant Lapatinib, Trastuzumab, and Their Combination in HER2-Positive Breast Cancer: Results from Neo-ALTTO.

Authors : Gebhart G, Gámez C, Holmes E, Robles J, Garcia C, Cortés M, de Azambuja E, Fauria K, van Dooren V, Aktan G, Coccia-Portugal MA, Kim SB, Vuylsteke P, Cure H, Eidtmann H, Baselga J, Piccart-Gebhart M, Flamen P, Di Cosimo S
Year : 2013
Journal : J. Nucl. Med.
Volume : 54(11)
Pages : 1862-8

Circulating tumor cells and response to neoadjuvant paclitaxel and HER2-targeted therapy: A sub-study from the NeoALTTO phase III trial.

Authors : Azim HA, Rothé F, Aura CM, Bavington M, Maetens M, Rouas G, Gebhart G, Gamez C, Eidtmann H, Baselga J, Piccart-Gebhart M, Ellis C, Vuylsteke P, Cure H, Domont J, Ferro A, Toral-Peña JC, de Azambuja E, Sotiriou C, Di Cosimo S, Ignatiadis M
Year : 2013
Journal : Breast
Volume : 22(6)
Pages : 1060-5

Role and interpretation of fluorodeoxyglucose-positron emission tomography/computed tomography in HIV-infected patients with fever of unknown origin: a prospective study.

Authors : Martin C, Castaigne C, Tondeur M, Flamen P, De Wit S
Year : 2013
Journal : HIV Med
Volume : 14(8)
Pages : 455-62

Planning cancer control in Latin America and the Caribbean.

Authors : Goss PE, Lee BL, Badovinac-Crnjevic T, Strasser-Weippl K, Chavarri-Guerra Y, Louis JS, Villarreal-Garza C, Unger-Saldaña K, Ferreyra M, Debiasi M, Liedke PE, Touya D, Werutsky G, Higgins M, Fan L, Vasconcelos C, Cazap E, Vallejos C, Mohar A, Knaul F, Arreola H, Batura R, Luciani S, Sullivan R, Finkelstein D, Simon S, Barrios C, Kightlinger R, Gelrud A, Bychkovsky V, Lopes G, Stefani S, Blaya M, Souza FH, Santos FS, Kaemmerer A, de Azambuja E, Zorilla AF, Murillo R, Jeronimo J, Tsu V, Carvalho A, Gil CF, Sternberg C, Dueñas-Gonzalez A, Sgroi D, Cuello M, Fresco R, Reis RM, Masera G, Gabús R, Ribeiro R, Knust R, Ismael G, Rosenblatt E, Roth B, Villa L, Solares AL, Leon MX, Torres-Vigil I, Covarrubias-Gomez A, Hernández A, Bertolino M, Schwartsmann G, Santillana S, Esteva F, Fein L, Mano M, Gomez H, Hurlbert M, Durstine A, Azenha G
Year : 2013
Journal : Lancet Oncol
Volume : 14(5)
Pages : 391-436

Preoperative chemosensitivity testing as Predictor of Treatment benefit in Adjuvant stage III colon cancer (PePiTA): Protocol of a prospective BGDO (Belgian Group for Digestive Oncology) multicentric study.

Authors : Hendlisz A, Golfinopoulos V, Deleporte A, Paesmans M, Mansy H, Garcia C, Peeters M, Annemans L, Vandeputte C, Maetens M, Borbath I, Dresse D, Houbier G, Fried M, Awada A, Piccart-Gebhart M, Laethem JL, Flamen P
Year : 2013
Journal : BMC Cancer
Volume : 13(1)
Pages : 190

New PET imaging agents in the management of solid cancers.

Authors : Garcia C, Gebhart G, Flamen P
Year : 2012
Journal : Curr Opin Oncol
Volume : 24(6)
Pages : 748-55

Lesion-based detection of early chemosensitivity using serial static FDG PET/CT in metastatic colorectal cancer.

Authors : Buvat I, Necib H, Garcia C, Wagner A, Vanderlinden B, Emonts P, Hendlisz A, Flamen P
Year : 2012
Journal : Eur J Nucl Med Mol Imaging
Volume : 39(10)
Pages : 1628-34

Surrogate markers predicting overall survival for lung cancer: ELCWP recommendations.

Authors : Berghmans T, Pasleau F, Paesmans M, Bonduelle Y, Cadranel J, CsToth I, Garcia C, Giner V, Holbrechts S, Lafitte JJ, Lecomte J, Louviaux I, Markiewicz E, Meert AP, Richez M, Roelandts M, Scherpereel A, Tulippe Ch, Van Houtte P, van Schil P, Wachters C, Westeel V, Sculier JP
Year : 2012
Journal : Eur. Respir. J.
Volume : 39(1)
Pages : 9-28

Serial FDG-PET/CT for early outcome prediction in patients with metastatic colorectal cancer undergoing chemotherapy.

Authors : Hendlisz A, Golfinopoulos V, Garcia C, Covas A, Emonts P, Ameye L, Paesmans M, Deleporte A, Machiels G, Toussaint E, Vanderlinden B, Awada A, Piccart-Gebhart M, Flamen P
Year : 2012
Journal : Ann Oncol
Volume : 23(7)
Pages : 1687-93